Tropicamide Solution/ Drops
NDC 85766-278
Product Information
Tropicamide is a ANDA-approved product labeled by Sportpharm Llc. This medication is used to widen (dilate) the pupil of the eye in preparation for certain eye examinations. It is supplied as a solution/ drops for ophthalmic administration. This product entry covers the primary NDC 85766-278 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 85766-278?
What are the uses of this product?
What are Active Ingredients of this product?
- TROPICAMIDE 10 mg/mL - One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TROPICAMIDE (UNII: N0A3Z5XTC6)
- TROPICAMIDE (UNII: N0A3Z5XTC6) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- BORIC ACID (UNII: R57ZHV85D4)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Tropicamide Ophthalmic
Tropicamide ophthalmic is used to cause pupil dilation (making the black center of the eye bigger) before an eye examination. Tropicamide is in a class of medications called mydriatics. It works by relaxing certain muscles in the eye.
[Learn More]
* Please review the full disclaimer at the bottom of this page.